Schwartz A, Wallick E T, Lee S W, Wang T, Hosakawa T, Whitmer K R, Matlib M A
Arzneimittelforschung. 1984;34(3A):384-9.
3,4-Dihydro-6-[4-(3,4- dimethoxybenzoyl )-piperazinyl]-2(1H)- quin olinone ( OPC -8212) is a new positive inotropic agent. In studies designed to elucidate information concerning its mechanism of action, its effect on Ca+ transport and related enzyme activities in sarcolemma, sarcoplasmic reticulum and mitochondria were studied. OPC -8212 was found to have little or no effect on these processes. The mechanism of action therefore is clearly different from other known positive inotropic drugs.
3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-哌嗪基]-2(1H)-喹啉酮(OPC-8212)是一种新型正性肌力药。在旨在阐明其作用机制相关信息的研究中,研究了它对肌膜、肌浆网和线粒体中Ca+转运及相关酶活性的影响。结果发现OPC-8212对这些过程几乎没有影响。因此,其作用机制明显不同于其他已知的正性肌力药物。